Sfoglia per Autore
Low rates of sustained virological response to interferon and ribavirin therapy in genotype 3 infected patients with compensated cirrhosis
2005 A. Aghemo, M. Rumi, R. D’Ambrosio, R. Soffredini, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
2006 M. Rumi, R. D'Ambrosio, A.M. Aghemo
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3α hepatitis C virus infection
2006 A. Aghemo, M.G. Rumi, R. Soffredini, R. D'Ambrosio, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
The international autoimmune hepatitis group scoring system in patients with chronic hepatitis C and serum autoantibodies undergoing interferon/ribavirin therapy : a prospective validation study
2006 V. Monti, A. Aghemo, M. Rumi, M.F. Donato, E. Arosio, R. D’Ambrosio, P. Lampertico, R. Soffredini, M. Colombo
Standard and pegylated interferon alfa-2b plus ribavirin as initial treatment for HCV genotype 2 chronic hepatitis : analysis of a large single center cohort
2006 M. Rumi, A. Aghemo, R. D’Ambrosio, G. Ronchi, S. Gallus, M. Colombo
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis : the interferon-inducible gene IFI16
2006 M. Mondini, M. Vidali, M. De Andrea, B. Azzimonti, P. Airò, R. D'Ambrosio, P. Riboldi, P. Meroni, E. Albano, Y. Shoenfeld, M. Gariglio, S. Landolfo
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients : a single-centre study
2007 M.G. Rumi, A.M. Aghemo, R. D'Ambrosio, G. Ronchi, E. Del Ninno, S. Gallus, M. Colombo
Hepatocellular carcinoma in patients with compensated HCV-related cirrhosis responding to interferon : A 5-year follow-up study
2008 M. Iavarone, A. Aghemo, M. Viganò, M.G. Rumi, A. Sangiovanni, M.F. Donato, R. D’Ambrosio, M. Colombo
The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy
2008 R. D’Ambrosio, A. Aghemo, M.G. Rumi, M. Primignani, A. Dell’Era, R. De Franchis, S. De Nicola, P. Lampertico, M. Colombo
Optimizing treatment with pegylated interferon-ribavirin of genotype 3 chronic hepatitis C : more questions than answers
2008 A. Aghemo, R. D’Ambrosio, M.G. Rumi, M. Colombo
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study
2009 A. Aghemo, M. Rumi, G.M. Prati, R. D’Ambrosio, S. De Nicola, M. Colombo
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated
2009 B.M. Dell’Osso, M. Rumi, G.M. Prati, A.M. Aghemo, R. D’Ambrosio, I. Balossi, N. D’Urso, F. Castellano, M. Palazzo, M. Colombo, A.C. Altamura
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study
2009 G.M. Prati, M. Rumi, A. Aghemo, R. D’Ambrosio, S. De Nicola, M. Colombo
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti
2009 M.G. Rumi, A. Aghemo, G.M. Prati, R. D’Ambrosio
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype
2009 A. Aghemo, M. Rumi, S. Monico, G.M. Prati, R. D'Ambrosio, M.F. Donato, M. Colombo
Randomized Study of Peginterferon-alpha2a Plus Ribavirin vs Peginterferon-alpha2b Plus Ribavirin in Chronic Hepatitis C
2010 M.G. Rumi, A. Aghemo, G.M. Prati, R. D'Ambrosio, M.F. Donato, R. Soffredini, E. Del Ninno, A. Russo, M. Colombo
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy
2011 R. D'Ambrosio, A. Aghemo, M. Rumi, M. Primignani, A. Dell' Era, P. Lampertico, M. F. Donato, S. De Nicola, G. M. Prati, R. de Franchis, M. Colombo
Ribavirin impairs salivary gland function in hepatitis C patients during combination treatment with pegylated interferon alfa-2a
2011 A.M. Aghemo, M. Rumi, S. Monico, M. Banderali, A. Russo, F. Ottaviani, M. Vigano, R. D'Ambrosio, M. Colombo
The diagnostic accuracy of fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR
2011 G.M. Prati, R. D’Ambrosio, M. Fraquelli, A. Aghemo, M. Rumi, G. Ronchi, V. Paradis, P. Bedossa, M. Colombo
Proteomics to predict hepatitis C therapy outcome : where do we stand?
2012 R. D'Ambrosio, M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile